Background illustration for clinical trials search

Paid Clinical Trials Ohio

Discover 3,048 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Relapsed Diffuse Large B-cell Lymphoma,
Location: West Reading PA, Greenville NC, Pittsburgh PA,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Sex: All

Age: 18+

Code: NCT04920617

Phase2, Recruiting

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

for
Acute Myeloid Leukemia
Location: Columbus OH
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 24

Code: NCT05503134

Phase1, Phase2, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase2, Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

for
Patellar Dislocation, Recurrent, Patellar Dislocation,
Location: Boston MA, New York NY, Wake Forest NC, Gainesville FL,
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 10 - 35

Code: NCT06883396

Recruiting

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

for
Acute Stroke, Ischemic Stroke, Stroke
Location: Worcester MA, New York NY, Philadelphia PA,
Sponsor: DiaMedica Therapeutics Inc

Sex: All

Age: 18 - 70+

Code: NCT05065216

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

for
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT04049539

Phase1, Phase2, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase1, Phase2, Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase1, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

for
Carpal Tunnel Syndrome
Location: Dayton OH
Sponsor: Kettering Health Network

Sex: All

Age: 18+

Code: NCT03867539

Recruiting

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Kerry Rogers

Sex: All

Age: 18+

Code: NCT06466122

Phase2, Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System

for
Corneal Ectasia, Keratoconus,
Location: Brecksville OH, Littleton CO
Sponsor: Colorado Eye Consultants/Cornea Consultants of Colorado

Sex: All

Age: 8+

Code: NCT04401865

Phase1, Phase2, Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

for
Heart Diseases, Coronary Artery Disease,
Location: St. John's, Saint John, Providence RI, Hartford CT,
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18+

Code: NCT04124120

Recruiting

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

for
Arrhythmogenic Right Ventricular Cardiomyopathy
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Tenaya Therapeutics

Sex: All

Age: 18 - 65

Code: NCT06228924

Phase1, Recruiting

Pediatric Dose Optimization for Seizures in Emergency Medical Services

for
Seizures
Location: Washington D.C. DC, Buffalo NY, Pittsburgh PA,
Sponsor: Stanford University

Sex: All

Age: 0 - 13

Code: NCT05121324

Phase3, Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05785741

Phase1, Phase2, Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

for
Overactive Bladder, Urinary Urgency Incontinence,
Location: New York NY, Bala-Cynwyd PA, Annapolis MD,
Sponsor: Axonics, Inc.

Sex: Male

Age: 18+

Code: NCT06511141

Recruiting

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Washington D.C. DC, Canton OH, Nashville TN
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase1, Phase2, Recruiting

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.

By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio